Skip to main content
. 2021 Mar 31;13(7):1615. doi: 10.3390/cancers13071615

Table 1.

Patient clinicopathological characteristics for the training and test sets.

Features Training Set (n = 396) Test Set (n = 132)
Freq. (%) Freq. (%)
Age
≤70 247 (62.4) 84 (63.6)
71–79 108 (27.3) 40 (30.3)
≥80 41 (10.4) 8 (6.1)
Gender
Male 237 (59.8) 78 (59.1)
Female 159 (40.2) 54 (40.9)
pT Stage
pT3 303 (76.5) 99 (75.0)
pT4 93 (23.5) 33 (25.0)
pN Stage
pN0 206 (52.0) 74 (56.1)
pN1 132 (33.3) 34 (25.8)
pN2 58 (14.6) 24 (18.2)
Tumour Site
Left 121 (30.6) 34 (25.8)
Right 114 (18.8) 39 (29.5)
Rectal 161 (40.7) 59 (44.7)
Differentiation
Moderate 206 (52.0) 59 (44.7)
Poor 25 (6.3) 18 (13.6)
Well 165 (41.7) 55 (41.7)
Tumour Type
Adenocarcinoma 378 (95.5) 121 (91.7)
Mucinous 18 (4.5) 11 (8.3)
DR type
Immature 94 (23.7) 31 (23.5)
Other 302 (76.3) 101 (76.5)

Abbreviations: Freq., frequency; DR, desmoplastic reaction.